arrow
W

Wungki Park

Memorial Sloan Kettering Cancer Center
H指数:32
被引数:6,551

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of Chemoimmunotherapy in Metastatic Pancreatic Neuroendocrine Carcinoma: A Single-Center Clinicopathologic Study

转移性胰腺神经内分泌癌的化疗免疫治疗效果:一项单中心临床病理研究

2026-10-280
OAAI
A health-system-scale, episode-resolved multimodal atlas of cancer cachexia

健康系统规模、按病程解析的多模态癌症恶病质图谱

2026-10-120
OA
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer

对RAS(ON) 多选择性抑制剂daraxonrasib的获得性耐药性指导胰腺癌的合理联合治疗策略

2026-08-110
OA
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

Pembrolizumab和olaparib治疗同源重组缺陷型转移性胰腺癌: 2期POLAR试验

2026-03-250
OAAI
Genomic evolution of pancreatic cancer at single-cell resolution

单细胞分辨率的胰腺癌基因组进化

2026-01-220
OAAI
ASO Visual Abstract: Outcomes of First-versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma

ASO视觉摘要:不可切除性肝内胆管癌中,一线与二线肝动脉灌注化疗的疗效比较

2025-11-170
PRE
Outcomes of First Versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma

不可切除性肝内胆管癌中,一线与二线肝动脉灌注化疗的疗效比较

2025-10-190
PRE
The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions

胰腺癌的非编码突变景观揭示了增强子区域中的复发体细胞突变

2025-10-010
PRE
Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma

生物学性别和肥胖对接受初次手术的胰腺腺癌患者肝脏复发和生存的影响

Cancer
IF5.1
2025-09-100
OAAI
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma

Keane, F.; Saadat, L.V.; O’Connor, C.A.; Chou, J.F.; Bowman, A.S.; Xu, F.; Crowley, F.; Debnath, N.; Schoenfeld, J.D.; Singhal, A.; 等. 循环肿瘤DNA在胰腺导管腺癌中的临床应用价值及组织一致性. J. Natl. Cancer Inst. 2025, 117, djaf139. [Google Scholar] [CrossRef]

2025-08-011
PRE
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy

技术上可切除的胰腺癌采用消融放射治疗的非手术治疗管理

2025-04-101
PRE
Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma
2024-11-221
OAAI
Automated real-world data integration improves cancer outcome prediction

自动化的真实世界数据集成可改善癌症结果预测

Nature
IF48.5
2024-11-060
OAAI
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis
2024-11-013
PRE
Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC)

一流的KRAS G12D选择性蛋白降解剂ASP3082在成人晚期胰腺癌 (PC),结直肠癌 (CRC) 和非小细胞肺癌 (NSCLC) 中的初步安全性和临床活性

2024-09-016
PRE